A revolutionary new class of 'contagious' vaccines is designed to spread naturally among populations. These innovative tools use benign, engineered carrier viruses that spread naturally from one animal to another, carrying a microscopic snippet of the target pathogen. Traditionally, vaccinating wildlife has been an impossible hurdle due to the sheer difficulty of capturing elusive animal populations. To overcome this, scientists created these "contagious" or transmissible vaccines. By vaccinating only a small fraction of a wild population — such as bats, rodents, or rabbits — the vaccine can quietly propagate through the community, building widespread herd immunity against deadly diseases like rabies, Lassa fever, and Ebola before they can infect humans. However, the prospect of releasing self-disseminating genetic agents into the wild has ignited intense scientific and ethical debate. Critics and cautious researchers warn of unpredictable risks, including the potential for the vaccine-virus to mutate back into a dangerous strain, or to inadvertently jump to non-target species. To address these concerns, international consortiums are advocating for rigorous safety frameworks, ensuring that these viral vectors are genetically stable and ecologically self-limiting. As research advances, finding the balance between proactive pandemic prevention and ecological safety remains one of modern science’s most critical challenges. source: Streicker, D. G., Griffiths, M. E., Antia, R., Bergner, L. M., Bowman, P., & Nuismer, S. L. (2024). Developing transmissible vaccines for animal infections. Science.